HOSA Pathophysiology Endocrine Practice Test

Excess osteoclastic activity due to hyperparathyroidism leads to demineralization of bone. In this condition, elevated levels of parathyroid hormone stimulate osteoclasts, which are cells responsible for bone resorption. As these osteoclasts become overactive, they break down bone tissue, releasing calcium into the bloodstream but also leading to a reduction in bone density.

The continuous demineralization decreases the structural integrity of bones, making them weaker and more susceptible to fractures. This process can result in significant skeletal issues, including an increased risk of osteoporotic conditions, characterized by loss of bone mass and compromised bone strength. The bone becomes less mineralized, which significantly impacts health and physical function.